Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of the presence and degree of carotid stenosis

被引：0
|
作者：
Mullenix, PS [1 ]
Steele, S [1 ]
Martin, M [1 ]
Starnes, B [1 ]
Andersen, C [1 ]
机构：
[1] Madigan Army Med Ctr, Tacoma, WA 98431 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2004年 / 199卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [41] Correlation of Oxidized Low-Density Lipoprotein and C-Reactive Protein in Patients with Coronary Artery Disease
    Yuli Huang
    Yanxian Wu
    Yunzhao Hu
    Cell Biochemistry and Biophysics, 2013, 65 : 285 - 286
  • [42] Correlation of Oxidized Low-Density Lipoprotein and C-Reactive Protein in Patients with Coronary Artery Disease
    Huang, Yuli
    Wu, Yanxian
    Hu, Yunzhao
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2013, 65 (02) : 285 - 286
  • [43] Ultra Low Levels of Low Density Lipoprotein Cholesterol in Primary Prevention in Subjects with Elevated C-Reactive Protein. Results of JUPITER
    Gratsiansky, N. A.
    KARDIOLOGIYA, 2009, 49 (01) : 73 - 75
  • [44] From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients
    Zenti, Maria G.
    Altomari, Anna
    Lupo, Maria G.
    Botta, Margherita
    Bonora, Enzo
    Corsini, Alberto
    Ruscica, Massimiliano
    Ferri, Nicola
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (17) : 1843 - 1851
  • [45] Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study
    Kraaijenhof, Jordan M.
    Nurmohamed, Nick S.
    Nordestgaard, Ask T.
    Reeskamp, Laurens F.
    Stroes, Erik S. G.
    Hovingh, G. Kees
    Boekholdt, S. Matthijs
    Ridker, Paul M.
    EUROPEAN HEART JOURNAL, 2025,
  • [46] Effect of Central Obesity, Low High-Density Lipoprotein Cholesterol and C-Reactive Protein Polymorphisms on C-Reactive Protein Levels During Treatment With Rosuvastatin (10 mg Daily)
    Hu, Miao
    Lee, Michael H. K.
    Mak, Valiant W. L.
    Tomlinson, Brian
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (11): : 1588 - 1593
  • [47] Prediction of low-density lipoprotein cholesterol levels using machine learning methods
    Kim, Yoori
    Lee, Won Kyung
    Lee, Woojoo
    LABORATORY MEDICINE, 2024, 55 (04) : 471 - 484
  • [48] Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment
    Lahoz, C
    Peña, R
    Mostaza, JM
    Laguna, F
    García-Iglesias, MF
    Taboada, M
    Pintó, X
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (06): : 741 - 747
  • [49] Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein
    Kampus, Priit
    Kals, Jaak
    Ristimae, Tiina
    Muda, Piibe
    Ulst, Kai
    Zilmer, Kersti
    Salonen, Riitta M.
    Tuomainen, Tomi-Pekka
    Teesalu, Rein
    Zilmer, Mihkel
    JOURNAL OF HYPERTENSION, 2007, 25 (04) : 819 - 825
  • [50] Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic review and meta-analysis
    Genser, B.
    Grammer, T. B.
    Stojakovic, T.
    Siekmeier, R.
    Maerz, W.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (10) : 497 - 510
12345